Global Cryopreservation for In-vitro Fertilization 麻豆原创 Research Report 2024

Publication ID:

PB505251432

Publication Date:

May 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global cryopreservation for in-vitro fertilization (IVF) market is likely to grow steadily with substantial improvements to pregnancy success rates in long term storage for reproductive materials. Favorable changes in regulations toward single parents, same sex couples, and older couples will create opportunities.
The global Cryopreservation for In-vitro Fertilization market was valued at US$ 3800 million in 2023 and is anticipated to reach US$ 7324.7 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.
The In Vitro Fertilization (IVF) Banking Service market is driven by the growing prevalence of infertility issues and the increasing awareness of assisted reproductive technologies among couples. IVF banking services offer the storage and preservation of embryos, eggs, or sperm for future use, providing individuals with a chance to conceive even after fertility issues arise. The convenience and flexibility offered by these services, allowing individuals to delay parenthood or preserve fertility due to medical reasons, contribute to market growth. Furthermore, advancements in cryopreservation techniques and improvements in the success rates of thawed embryos enhance the attractiveness of IVF banking services. However, challenges include the high costs associated with these services, ethical concerns related to the storage of embryos, and varying regulations across different regions. Addressing these challenges through cost-effective pricing models, increased public awareness, and adherence to ethical guidelines is essential for the sustained growth of the IVF Banking Service market. The market's potential to offer hope to couples facing fertility challenges and its alignment with changing societal trends make it a prominent segment in the reproductive medicine landscape.
This report aims to provide a comprehensive presentation of the global market for Cryopreservation for In-vitro Fertilization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cryopreservation for In-vitro Fertilization.
Report Scope
The Cryopreservation for In-vitro Fertilization market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cryopreservation for In-vitro Fertilization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cryopreservation for In-vitro Fertilization companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Thermo Fisher Scientific
Merck
Fujifilm Irvine Scientific
Vitrolife AB
Kitazato
Brooks Life Sciences
Corning
Bio-Match Tech Ltd.
Cryo Solutions B.V.
Cryogatt Systems Ltd.
Kustodian
ColdStash
Segment by Type
Cryopreservation Media
Cryopreservation Storage Devices
Consumables & Accessories
Other
Segment by Application
Biobanks
IVF & Fertility Clinics
Research & Academic Institutes
Cryo-shipping/couriers
Cryo Monitoring /Inventory Management
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cryopreservation for In-vitro Fertilization companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cryopreservation for In-vitro Fertilization 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cryopreservation Media
1.2.3 Cryopreservation Storage Devices
1.2.4 Consumables & Accessories
1.2.5 Other
1.3 麻豆原创 by Application
1.3.1 Global Cryopreservation for In-vitro Fertilization 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biobanks
1.3.3 IVF & Fertility Clinics
1.3.4 Research & Academic Institutes
1.3.5 Cryo-shipping/couriers
1.3.6 Cryo Monitoring /Inventory Management
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cryopreservation for In-vitro Fertilization 麻豆原创 Perspective (2019-2030)
2.2 Cryopreservation for In-vitro Fertilization Growth Trends by Region
2.2.1 Global Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cryopreservation for In-vitro Fertilization Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Cryopreservation for In-vitro Fertilization Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Cryopreservation for In-vitro Fertilization 麻豆原创 Dynamics
2.3.1 Cryopreservation for In-vitro Fertilization Industry Trends
2.3.2 Cryopreservation for In-vitro Fertilization 麻豆原创 Drivers
2.3.3 Cryopreservation for In-vitro Fertilization 麻豆原创 Challenges
2.3.4 Cryopreservation for In-vitro Fertilization 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cryopreservation for In-vitro Fertilization Players by Revenue
3.1.1 Global Top Cryopreservation for In-vitro Fertilization Players by Revenue (2019-2024)
3.1.2 Global Cryopreservation for In-vitro Fertilization Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Cryopreservation for In-vitro Fertilization 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cryopreservation for In-vitro Fertilization Revenue
3.4 Global Cryopreservation for In-vitro Fertilization 麻豆原创 Concentration Ratio
3.4.1 Global Cryopreservation for In-vitro Fertilization 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cryopreservation for In-vitro Fertilization Revenue in 2023
3.5 Cryopreservation for In-vitro Fertilization Key Players Head office and Area Served
3.6 Key Players Cryopreservation for In-vitro Fertilization Product Solution and Service
3.7 Date of Enter into Cryopreservation for In-vitro Fertilization 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cryopreservation for In-vitro Fertilization Breakdown Data by Type
4.1 Global Cryopreservation for In-vitro Fertilization Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Cryopreservation for In-vitro Fertilization Forecasted 麻豆原创 Size by Type (2025-2030)
5 Cryopreservation for In-vitro Fertilization Breakdown Data by Application
5.1 Global Cryopreservation for In-vitro Fertilization Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Cryopreservation for In-vitro Fertilization Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Cryopreservation for In-vitro Fertilization 麻豆原创 Size (2019-2030)
6.2 North America Cryopreservation for In-vitro Fertilization 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Country (2019-2024)
6.4 North America Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cryopreservation for In-vitro Fertilization 麻豆原创 Size (2019-2030)
7.2 Europe Cryopreservation for In-vitro Fertilization 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Country (2019-2024)
7.4 Europe Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cryopreservation for In-vitro Fertilization 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Cryopreservation for In-vitro Fertilization 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cryopreservation for In-vitro Fertilization 麻豆原创 Size (2019-2030)
9.2 Latin America Cryopreservation for In-vitro Fertilization 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cryopreservation for In-vitro Fertilization 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Cryopreservation for In-vitro Fertilization 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Cryopreservation for In-vitro Fertilization 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cryopreservation for In-vitro Fertilization Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Cryopreservation for In-vitro Fertilization Introduction
11.2.4 Merck Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Fujifilm Irvine Scientific
11.3.1 Fujifilm Irvine Scientific Company Detail
11.3.2 Fujifilm Irvine Scientific Business Overview
11.3.3 Fujifilm Irvine Scientific Cryopreservation for In-vitro Fertilization Introduction
11.3.4 Fujifilm Irvine Scientific Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.3.5 Fujifilm Irvine Scientific Recent Development
11.4 Vitrolife AB
11.4.1 Vitrolife AB Company Detail
11.4.2 Vitrolife AB Business Overview
11.4.3 Vitrolife AB Cryopreservation for In-vitro Fertilization Introduction
11.4.4 Vitrolife AB Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.4.5 Vitrolife AB Recent Development
11.5 Kitazato
11.5.1 Kitazato Company Detail
11.5.2 Kitazato Business Overview
11.5.3 Kitazato Cryopreservation for In-vitro Fertilization Introduction
11.5.4 Kitazato Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.5.5 Kitazato Recent Development
11.6 Brooks Life Sciences
11.6.1 Brooks Life Sciences Company Detail
11.6.2 Brooks Life Sciences Business Overview
11.6.3 Brooks Life Sciences Cryopreservation for In-vitro Fertilization Introduction
11.6.4 Brooks Life Sciences Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.6.5 Brooks Life Sciences Recent Development
11.7 Corning
11.7.1 Corning Company Detail
11.7.2 Corning Business Overview
11.7.3 Corning Cryopreservation for In-vitro Fertilization Introduction
11.7.4 Corning Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.7.5 Corning Recent Development
11.8 Bio-Match Tech Ltd.
11.8.1 Bio-Match Tech Ltd. Company Detail
11.8.2 Bio-Match Tech Ltd. Business Overview
11.8.3 Bio-Match Tech Ltd. Cryopreservation for In-vitro Fertilization Introduction
11.8.4 Bio-Match Tech Ltd. Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.8.5 Bio-Match Tech Ltd. Recent Development
11.9 Cryo Solutions B.V.
11.9.1 Cryo Solutions B.V. Company Detail
11.9.2 Cryo Solutions B.V. Business Overview
11.9.3 Cryo Solutions B.V. Cryopreservation for In-vitro Fertilization Introduction
11.9.4 Cryo Solutions B.V. Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.9.5 Cryo Solutions B.V. Recent Development
11.10 Cryogatt Systems Ltd.
11.10.1 Cryogatt Systems Ltd. Company Detail
11.10.2 Cryogatt Systems Ltd. Business Overview
11.10.3 Cryogatt Systems Ltd. Cryopreservation for In-vitro Fertilization Introduction
11.10.4 Cryogatt Systems Ltd. Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.10.5 Cryogatt Systems Ltd. Recent Development
11.11 Kustodian
11.11.1 Kustodian Company Detail
11.11.2 Kustodian Business Overview
11.11.3 Kustodian Cryopreservation for In-vitro Fertilization Introduction
11.11.4 Kustodian Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.11.5 Kustodian Recent Development
11.12 ColdStash
11.12.1 ColdStash Company Detail
11.12.2 ColdStash Business Overview
11.12.3 ColdStash Cryopreservation for In-vitro Fertilization Introduction
11.12.4 ColdStash Revenue in Cryopreservation for In-vitro Fertilization Business (2019-2024)
11.12.5 ColdStash Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Thermo Fisher Scientific
Merck
Fujifilm Irvine Scientific
Vitrolife AB
Kitazato
Brooks Life Sciences
Corning
Bio-Match Tech Ltd.
Cryo Solutions B.V.
Cryogatt Systems Ltd.
Kustodian
ColdStash

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.